APA (7th ed.) Citation

Van de Wiele, V. L., Hammer, M., Parikh, R., Feldman, W. B., Sarpatwari, A., & Kesselheim, A. S. (2022). Competition law and pricing among biologic drugs: The case of VEGF therapy for retinal diseases. Journal of law and the biosciences, 9(1), . https://doi.org/10.1093/jlb/lsac001

Chicago Style (17th ed.) Citation

Van de Wiele, Victor L., Maximilian Hammer, Ravi Parikh, William B. Feldman, Ameet Sarpatwari, and Aaron S. Kesselheim. "Competition Law and Pricing Among Biologic Drugs: The Case of VEGF Therapy for Retinal Diseases." Journal of Law and the Biosciences 9, no. 1 (2022). https://doi.org/10.1093/jlb/lsac001.

MLA (9th ed.) Citation

Van de Wiele, Victor L., et al. "Competition Law and Pricing Among Biologic Drugs: The Case of VEGF Therapy for Retinal Diseases." Journal of Law and the Biosciences, vol. 9, no. 1, 2022, https://doi.org/10.1093/jlb/lsac001.